-
Product Insights
NewComputed Tomography (CT) Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional image of an object from a flat X-ray image. Computed Tomography (CT) is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with high risk of heart disease. It can also be used for image complex fractures, detect infarction, tumors, calcifications, hemorrhage and bone trauma and also acute and chronic changes in the lung parenchyma etc. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FOG-001 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FOG-001 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FOG-001 in Gastric Cancer Drug Details: FOG-001 is under development of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FOG-001 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FOG-001 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FOG-001 in Non-Small Cell Lung Cancer Drug Details: FOG-001...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FOG-001 in Gastroesophageal (GE) Junction Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FOG-001 in Gastroesophageal (GE) Junction Carcinomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FOG-001 in Gastroesophageal (GE) Junction Carcinomas Drug Details: FOG-001...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FOG-001 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FOG-001 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FOG-001 in Metastatic Colorectal Cancer Drug Details: FOG-001 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FOG-001 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FOG-001 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FOG-001 in Solid Tumor Drug Details: FOG-001 is under development of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GM-2505 in Psychiatric Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GM-2505 in Psychiatric Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GM-2505 in Psychiatric Disorders Drug Details: GM-2505 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Benzoyl Peroxide + Tretinoin) in Acne Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Benzoyl Peroxide + Tretinoin) in Acne Vulgaris report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Benzoyl Peroxide + Tretinoin) in Acne Vulgaris Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GM-2505 in Anxiety Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GM-2505 in Anxiety Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GM-2505 in Anxiety Disorders Drug Details: GM-2505 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GM-2505 in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GM-2505 in Major Depressive Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GM-2505 in Major Depressive Disorder Drug Details: GM-2505 is under...